Randomized placebo controlled trials of n-acetyl cysteine as adjunct therapy for schizophrenia and bipolar disorder Bush, Ashley, Dean, Olivia, Copolov, D. L. and Berk, M. 2009, Randomized placebo controlled trials of n-acetyl cysteine as adjunct therapy for schizophrenia and bipolar disorder, in WFSBP Congress 2009 : Proceedings of the 9th World Congress of Biological Psychiatry, World Federation of Societies of Biological Psychiatry,. Attached Files Name Description MIMEType Size Downloads dean-randomizedplacebo-2009.pdf Published version application/pdf 448.32KB 244 Title Randomized placebo controlled trials of n-acetyl cysteine as adjunct therapy for schizophrenia and bipolar disorder Author(s) Bush, Ashley Dean, Olivia orcid.org/0000-0002-2776-3935 Copolov, D. L. Berk, M. orcid.org/0000-0002-5554-6946 Conference name World Congress of Biological Psychiatry (9th : 2009 : Paris, France) Conference location Paris, France Conference dates 28 Jun. - 2 Jul. 2009 Title of proceedings WFSBP Congress 2009 : Proceedings of the 9th World Congress of Biological Psychiatry Editor(s) [Unknown] Publication date 2009 Publisher World Federation of Societies of Biological Psychiatry Summary Glutathione is the principal antioxidant of the brain. There is evidence of oxidative stress, lowered brain glutathione and genetic linkage involve glutathione metabolic genes in schizophrenia and bipolar disorder. N-acetyl cysteine (NAC) is a safe, orally bioavailable, precursor of glutathione. NAC has been shown to reverse animal models of oxidative stress, and raises brain glutathione levels. Notes Presented during a Free Communication session Every reasonable effort has been made to ensure that permission has been obtained for items included in Deakin Research Online. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au Language eng Field of Research 119999 Medical and Health Sciences not elsewhere classified Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences HERDC Research category EN.1 Other conference paper Copyright notice ©2009, World Federation of Societies of Biological Psychiatry Free to Read? Yes Persistent URL http://hdl.handle.net/10536/DRO/DU:30035451 Document type: Conference Paper Collections: Faculty of Health School of Medicine Open Access Collection   Link to Related Work Randomized placebo controlled trials of n-acetyl cysteine as adjunct therapy for schizophrenia and bipolar disorder (deposited 13-12-2021) World Congress of Biological Psychiatry (WCBP) Publisher (deposited 16-07-2013)   Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au. Versions Version Filter Type Tue, 21 Jun 2011, 14:33:12 EST Fri, 18 Nov 2011, 09:24:19 EST Fri, 18 Nov 2011, 09:25:38 EST Mon, 11 Nov 2013, 11:58:45 EST Tue, 05 Dec 2017, 10:51:16 EST Fri, 07 Sep 2018, 15:27:48 EST Filtered Full Citation counts:   Cited 0 times in TR Web of Science Cited 0 times in Scopus Search Google Scholar Access Statistics: 360 Abstract Views, 244 File Downloads  -  Detailed Statistics Created: Tue, 21 Jun 2011, 14:33:12 EST